Our vision is to become a leading innovative rapid diagnostic testing company.
We strongly believe that in many areas there are significant clinical and economic benefits to the introduction of rapid diagnostic testing. Our aim is to support the migration of testing closer to the patient, in the case of clinical diagnostics or veterinary diagnostics, or into the field or farm, in the case of agricultural and food and feed diagnostics.
Our technology focus is the lateral flow rapid testing market, a US$5bn market growing at a rate of 8% per annum (Source: Markets and Markets). The convergence of a number of factors including: diagnostic technology improvements; the emergence of “big data”; and an increasingly connected world (e.g. the Cloud) are driving this growth in rapid testing.
Delivering on the strategic objectives set out below as well as promoting excellence in our four building blocks will help us achieve our vision to the benefit of all our stakeholders including investors, employees, customers, and suppliers.
Our strategic objectives are:
© Abingdon Health 2019